Zydus Lifesciences Share Price

₹ 1,196.70

-₹43.90 (-3.54%)
1D
Last updated 04 Nov, 2026, 13:05 IST
NSE: ZYDUSLIFE
|
Pharmaceuticals

Zydus Lifesciences Share Price Today

As of 4 Nov 2026, Zydus Lifesciences share price is ₹1,196.70. The stock opened at ₹1,246.00, compared to its previous close of ₹1,240.60. During today's trading session, Zydus Lifesciences share price moved in the range of ₹1,182.40 to ₹1,266.60, with an average price of ₹1,224.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹835.50 and a high of ₹1,266.60. On the performance front, Zydus Lifesciences share price has increased by 39.10% over the last six months and is up 26.46% on a year-on-year basis.

Share price over the last 1 day fell from 1253.80 to 1198.70, ranging between 1184.80 and 1266.00.
₹1,182.40
3.54% down today
₹1,266.60
1D LOW
1D HIGH

Zydus Lifesciences Stock Insights

Latest Earning
Op Profit TrendUp by 9.86% YoY
Latest Earning
Net Profit TrendUp by 8.92% YoY
Latest Earning
Revenue TrendUp by 5.21% QoQ
Stock Performance
OutperformingBeat Nifty by 4.99 % in last 1 month
Shareholding Pattern
DIIDII decreased stake by 28.52%
Shareholding Pattern
FIIFII increased stake by 2.35%
Zydus Lifesciences stock performance
Open₹1,246.00
High₹1,266.60
Low₹1,182.40
Prev. close₹1,240.60
Zydus Lifesciences trading activity
Volume31,04,780
Average traded price₹1,221.99
Last traded time01:05:26 04 Nov
Last traded quantity1
Circuit
L
H
₹1,116.60
₹1,364.60
52-week
L
H
₹835.50
₹1,266.60
Mkt Cap Cr
1,23,685.49
P/E
26.93
P/B
4.56
ROA
8.57%
ROE
18.59%
ROCE
17.35%
Quick Ratio
0.91
EV/EBITDA
16.42

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Zydus Lifesci. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Zydus Lifesci. appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Zydus Lifesci. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4784.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,26,811.2894.0820.6811.58%22.11%20.91%0.6853.48
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76
Glenmark Pharma67,395.2537.766.469.03%28.08%32.7%1.2319.87

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Zydus Lifesciences Company Background

ISIN
INE010B01027
Sector Market Cap
₹ 123,685.49 Cr

Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.

Zydus Lifesciences Financial Highlights

  • Revenue: Zydus Lifesciences reported revenue of ₹27,657.90 crore in FY26 vs ₹23,511.00 crore in FY25. It showed an increase of 17.64% on a yearly basis.
  • Operating Profit: Zydus Lifesciences reported an operating profit of ₹6,621.10 crore in FY26 vs ₹6,026.70 crore in FY25. It showed an increase of 9.86% on a year-on-year basis.
  • Net Profit: Zydus Lifesciences reported a net profit of ₹5,026.40 crore in FY26 vs ₹4,614.80 crore in FY25. It showed an increase of 8.92% on a yearly basis.

Zydus Lifesciences Quarterly Result Highlights

  • Zydus Lifesciences reported revenue of ₹8,123.10 crore in Jun 2026, compared with ₹7,721.20 crore in Mar 2026, representing an increase of 5.21% on a quarter-on-quarter (QoQ) basis.
  • Zydus Lifesciences reported an operating profit of ₹1,306.60 crore in Jun 2026, compared with ₹1,659.70 crore in Mar 2026, representing a decrease of 21.27% on a quarter-on-quarter (QoQ) basis.
  • Zydus Lifesciences reported a profit of ₹952.40 crore in Jun 2026, compared with ₹1,341.30 crore in Mar 2026, reflecting a decrease of 28.99% on a QoQ basis.
  • The earnings per share (EPS) of Zydus Lifesciences stood at ₹50.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.01%
FII
7.05%
Other DII
4.40%
Retail and other
6.66%
Mutual funds
6.88%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20257.06%
Mar 20266.95%
Jun 20266.88%
Sep 20267.05%

Zydus Lifesciences Investment Returns

1 day
+0.01%
1 week
+5.77%
1 month
+8.28%
1 year
+26.46%
3 years
+112.12%
5 years
+152.93%

Zydus Lifesciences Share Price History

Zydus Lifesciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹1,244.70 / ₹1,240.60
+0.01%
02 Nov 26
₹1,250.00 / ₹1,240.50
-0.40%
30 Oct 26
₹1,190.00 / ₹1,245.50
+5.16%
29 Oct 26
₹1,175.50 / ₹1,184.40
+0.76%
Show more

Zydus Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹27,148.40₹23,241.50₹19,547.40₹17,237.40
Other Income₹509.50₹269.50₹284.10₹186.60
Total Revenue₹27,657.90₹23,511.00₹19,831.50₹17,424.00
Total Expenses₹20,520.20₹17,264.70₹15,008.40₹14,230.10
Profit Before Tax₹6,621.10₹6,026.70₹4,808.90₹2,589.70
Tax₹1,594.70₹1,411.90₹977.50₹587.80
Profit After Tax₹5,026.40₹4,614.80₹3,831.40₹2,001.90
EPS - Basic₹50.09₹44.97₹38.14₹19.30
EPS - Diluted₹50.09₹44.97₹38.14₹19.30

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6,621.10₹6,026.70₹4,838.10₹2,582.70
Income before WC changes₹6,331.30₹7,047.10₹5,384.80₹3,516.60
Change in Assets-₹1,732.30₹926.20-₹890.60-₹261.90
Change in Liabilities-₹891.40₹609.70-₹12.10₹26.10
Change in WC-₹2,623.70₹1,535.90-₹902.70-₹235.80
Cash flow from Operations₹2,116.60₹6,781.10₹3,196.30₹2,688.80
Cash flow from Investing-₹8,296.10-₹8,357.80-₹1,475.20₹1,535.00
Cash flow from Financing₹5,806.90₹1,995.30-₹1,778.80-₹4,400.40
Total Cash Flow-₹372.60₹418.60-₹57.70-₹176.60
Cash (Start of the year)₹826.80₹413.00₹487.80₹657.80
Cash (End of the year)₹855.20₹826.80₹413.00₹487.80

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹32,500.50₹20,155.60₹17,861.00₹15,748.20
Current Assets₹19,906.10₹17,046.10₹11,419.80₹10,008.20
Total Assets₹52,406.60₹37,201.70₹29,280.80₹25,756.40
Current Liabilities₹15,711.90₹9,041.60₹5,339.70₹5,526.70
Net Current Asset₹4,194.20₹8,004.50₹6,080.10₹4,481.50
Non-Current Liabilities₹7,112.50₹1,801.70₹1,839.50₹541.40
Equity Capital₹29,582.20₹26,358.40₹22,101.60₹19,688.30
Total Equity & Liabilities₹52,406.60₹37,201.70₹29,280.80₹25,756.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹11,484.00₹15,116.30₹10,818.70₹8,731.60
Other Income₹1,667.50₹696.20₹1,084.80₹548.40
Total Revenue₹13,151.50₹15,812.50₹11,903.50₹9,280.00
Total Expenses₹8,602.70₹8,367.80₹7,655.10₹7,044.00
Profit Before Tax₹4,381.90₹7,444.70₹4,239.80₹2,032.20
Tax₹822.10₹1,669.80₹798.30₹503.00
Profit After Tax₹3,559.80₹5,774.90₹3,441.50₹1,529.20
EPS - Basic₹35.38₹57.39₹34.01₹15.06
EPS - Diluted₹35.38₹57.39₹34.01₹15.06

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4,381.90₹7,444.70₹4,239.80₹2,032.20
Income before WC changes₹3,096.50₹7,769.80₹4,090.80₹2,507.30
Change in Assets₹10.10-₹3,467.20-₹1,272.50-₹1,070.60
Change in Liabilities₹173.60₹159.50₹79.70₹34.70
Change in WC₹183.70-₹3,307.70-₹1,192.80-₹1,035.90
Cash flow from Operations₹2,234.30₹3,114.00₹2,000.30₹1,078.20
Cash flow from Investing₹569.60-₹4,503.60-₹1,831.80-₹1,959.30
Cash flow from Financing-₹2,579.90₹1,384.50-₹300.80₹827.00
Total Cash Flow₹224.00-₹5.10-₹132.30-₹54.10
Cash (Start of the year)₹103.00₹108.10₹240.40₹294.50
Cash (End of the year)₹327.00₹103.00₹108.10₹240.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹17,627.80₹17,002.20₹16,173.50₹13,405.40
Current Assets₹16,251.80₹15,314.70₹7,911.30₹7,158.20
Total Assets₹33,879.60₹32,316.90₹24,084.80₹20,563.60
Current Liabilities₹5,592.60₹7,851.40₹2,541.40₹2,790.10
Net Current Asset₹10,659.20₹7,463.30₹5,369.90₹4,368.10
Non-Current Liabilities₹4,615.30₹3,275.40₹5,826.90₹4,134.10
Equity Capital₹23,671.70₹21,190.10₹15,716.50₹13,639.40
Total Equity & Liabilities₹33,879.60₹32,316.90₹24,084.80₹20,563.60
* All values are in INR Crore
Zydus Lifesciences market depth
Bid quantityBid priceAsk priceAsk quantity
11196.41196.73
231196.21196.88
651196.11196.9171
58411961197224
731195.91197.1121
Total bid quantity746
Total ask quantity527
Zydus Lifesciences technical summary
Bearish indicators4
Neutral indicators2
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
69.29
Neutral
ATR (14)
33.66
Neutral
STOCH(9,6)
91.54
Bearish
STOCH RSI (14)
94.4
Bearish
ADX(9)
19.75
Bullish
UO(9)
75.49
Bearish
ROC(12)
8.81
Bullish
WillR(14)
-8.46
Bearish
Period
Simple value
Exponential vaue
5D
1217.3
1219.53
10D
1180.15
1194.29
20D
1155.61
1173.13
50D
1152.9
1153.3
100D
1137.73
1122.55
Volume trend — traded volume by day
4 Nov30L
3 Nov18L
2 Nov11L
30 Oct36L
29 Oct8L
28 Oct5L
Average18L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Zydus Lifesciences
Pharmaceuticals
Add Stock
Add Another

Zydus Lifesciences Returns Calculator

Ex-date: 24 Jul 2026

Zydus Lifesciences Latest News

3 weeks ago
Dr Reddy’s, Torrent Pharma, Zydus Life: Pharma stocks to post resilient growth in Q2 earnings despite pricing headwinds
1 month ago
Zydus Life, Engineers India to Raymond: Top 10 stocks that hit 52-week high amid stock market crash; check full list
1 month ago
PB Fintech, Zydus Life, PC Jeweller among buzzing stocks as SENSEX tanks over 900 pts; NIFTY falls 1.3%
1 month ago
Zydus Lifesciences shares jump 2% to hit 52-week high as US FDA concludes inspection at New Jersey office
1 month ago
Welspun Corp., MCX to Zydus Life: Top five Nifty 500 stocks that hit 52-week high on Sept 25; check full list
1 month ago
Sun Pharma to Zydus: Healthcare stocks outperform broader market despite price pressure; can they sustain growth?
2 months ago
Zydus Lifesciences shares rise as US FDA approves Ascorbic Acid injection with 180-day CGT exclusivity
2 months ago
Zydus Lifesciences Q1 results: Net profit falls 36% YoY to ₹940 crore, revenue surges 22%; shares jump 5%
3 months ago
Q3 Results Today: BSE, Zydus Lifesciences, Aurobindo Pharma, Pfizer, GSK, Ramco Cements, PNG, others to post earnings on Feb 9; check list
3 months ago
Sun Pharma, Cipla, other pharma stocks decline as Trump unveils steep tariff plan on generic drugs: Key FAQs answered
Showing news item 1 of 10

Top Gainers

SAREGAMA Share Price
₹618.10
+55.9 (+9.94%)
GMDCLTD Share Price
₹466.25
+40.65 (+9.55%)
EQUITASBNK Share Price
₹56.97
+4.32 (+8.21%)
LINDEINDIA Share Price
₹6271.00
+422.5 (+7.22%)
UNOMINDA Share Price
₹1200.40
+75.9 (+6.75%)
See more

Top Losers

SKFINDIA Share Price
₹1391.50
-80.4 (-5.46%)
AIAENG Share Price
₹3228.60
-161.1 (-4.75%)
ALKYLAMINE Share Price
₹1585.20
-73.6 (-4.44%)
ZYDUSLIFE Share Price
₹1198.00
-42.6 (-3.43%)
BATAINDIA Share Price
₹628.00
-21.8 (-3.35%)
See more

Zydus Lifesciences Share Price FAQs

Please be aware that Zydus Lifesciences stock prices are subject to continuous fluctuations due to various factors.